
0:00
1:03:18
Moderator: SABCS Co-director Virginia Kaklamani, MD, leader of the Breast Cancer Program at the Cancer Therapy & Research Center and professor of medicine at the UT Health Science Center San Antonio
- Capecitabine Improved Outcomes for Breast Cancer Patients With Residual Disease After Presurgery Chemotherapy;
- Women With Luminal A Subtype of Breast Cancer Did Not Benefit From Adjuvant Chemotherapy;
- Denosumab Improves Disease-free Survival for Postmenopausal Patients With HR-positive Breast Cancer; and
- Pathologic Complete Response to Presurgery Chemotherapy Improves Survival For Patients With Triple-negative Breast Cancer.
Altri episodi di "AACR Scientific Podcasts"



Non perdere nemmeno un episodio di “AACR Scientific Podcasts”. Iscriviti all'app gratuita GetPodcast.



